Effect of Wumeiwan on cytokines TNF-α, IL-6, IL-8, IL-10 and expression of NF-κBp65 in rats with ulcerative colitis

Abstract

The effects of Wumeiwan (WMW) on TNF-α, IL-6, IL-8, IL-10 and NF-κBp65 in rats with ulcerative colitis (UC) were investigated, the curative effectiveness of WMW vs salicylazosulfapyridine (SASP) was compared, and the action mechanism was analyzed. Fifty-Six Sprague-Dawley (SD) rats were randomly divided into four groups (n=14 in each group, with equal ratio of male and female): normal control group, model group, SASP group, and WMW group. Except normal control group, the rat UC models in the remaining three groups were established using the method of 2.4-dinitrochlorobenzene (DNCB) immunization and acetic acid local enema. The rats in model group, SASP group, and WMW group were treated with distilled water, SASP, and WMW respectively. The changes in the symptoms and signs were observed, and levels of IL-6, IL-8, TNF-α, IL-10 and the expression of NF-κBp65 in the colonic tissues were statistically analyzed. The results showed that the levels of IL-6, IL-8, and TNF-α were significantly increased (P<0.01), while those of IL-10 significantly reduced (P<0.01) after establishment of rat UC models as compared with normal control group. The levels of IL-6, IL-8, and TNF-α were obviously lower, but the level of IL-10 was obviously higher in WMW and SASP groups than those in model group (P<0.05). The levels of IL-6, IL-8, and TNF-α were lower, while the level of IL-10 was higher in WMW group than in SASP group. NF-κBp65 was expressed negatively or weakly in normal colonic tissues. The positive expression rate of NF-κBp65 in WMW group and SASP group was obviously lower than in model group (P<0.01), and there was significant difference between WMW group and SASP group (P<0.05). It was concluded that rat UC model was established successfully. WMW could up-regulate the expression of IL-10, down-regulate the expression of TNF-α, IL-6, IL-8, and inhibit the NF-κBp65 activity to adjust immune function, indicating WMW had better curative effects on UC in rats.

Keywords

ulcerative colitis / TCM therapy / cytokine / Wumeiwan

References

[1] HuR.W.. Cytokine and inflammatory bowel disease. Guowai Yixue Xiaohuaxi Jibing Fence (Chinese), 1998, 18(3): 146-148

[2] NeurathM.F., PetterssonS., Meyer zum BüschenfeldeK.H., et al.. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat Med, 1996, 2(9): 998-1004

[3] BicksR.O., RosenbergE.W.. A chronic delayed hypersensitivity reaction in the guinea pig colon. Gastroenterology, 1964, 46(5): 543

[4] LiY.. Methods on making rat experiment model of ulcerative colitis. Zhongyao Xinyao Yu Linchuang Yaoli (Chinese), 1999, 10(3): 120-122

[5] JiangX.L., QuanQ.Z., WangD., et al.. A new ulcerative colitis model induced by compound method and the change of immunity and ultrastructures. Shijie Huaren Xiaohua Zazhi (Chinese), 1999, 7(5): 381-383

[6] FanH., QiuM.Y.. Evaluating on making rat experiment model of ulcerative colitis. Zhongyiyao Xuekan (Chinese), 2004, 22(5): 865-866

[7] FanH., QiuM.Y., MeiJ.J., et al.. Effect of Lichangsifang on cellular apoptosis and expression of the related regulatory genes in rats with ulcerative colitis. Shijie Huaren Xiaohua Zazhi (Chinese), 2004, 12(5): 1119-1124

[8] ZhengL., GaoZ.Q., WangS.X.. A chronic ulcerative colitis model in rats. World J Gastroenterol Chinese, 2000, 6(1): 150-152

[9] QiuM.Y., FanH., MeiJ.J., et al.. Effect of Lichangsifang on expression of TNF-α mRNA in rats with ulcerative colitis. Shijie Huaren Xiaohua Zazhi (Chinese), 2004, 12(3): 706-710

[10] GoetzlE.J., BurrallB.A., BaudL., et al.. Generation and recognition of leukotriene mediators of hypersensitivity and inflammation. Dig Dis Sci, 1988, 33(Suppl3): S36-S40

[11] YiaoY.B., QiuM.Y., CaiH., et al.. Effect of Wumeiwan on histiocyte factors TNF-α, IL-8 and IL-10 of rats with ulcerative colitis. JTCM (Chinese), 2002, 43(12): 935-737

[12] PedersenG., SaermarkT., BendtzenK., et al.. Culture of human colonic epithelial cells isolated from endoscopical biopsis from patients with inflammatory bowel disease. Effect of IFN-gamma, TNF-alpha and IL-1 beta on viability, butyrate oxidation and IL-8 secretion. Autoimmunity, 2000, 32(4): 255-263

[13] AkazawaA., SakaidaI., HigakiS., et al.. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase. J Gastroenterol, 2002, 37(5): 345-353

[14] IndaramA.V., VisvalingamV., LockeM., et al.. Mucosal cytokine production in radiation-induced proctosigmoiditis compared with inflammatory bowel disease. Am J Gastroenterol, 2002, 95(5): 1221-1225

[15] TianL., HuangY.X., WenQ.S., et al.. Therapeutic effect and mechanism of electro-acupuncture on rats with ulcerative colitis. Shijie Huaren Xiaohua Zazhi (Chinese), 2002, 10(8): 916-921

[16] BaD.N.. Cytokine—Language assorted with immunity respondent and drugs of biology technique of treatment disease. Acat Academiae Medicine Sinicae, 2001, 23(2): 103-105

[17] ImadaA., InaK., ShimadaM., et al.. Coordinate upregulation of interleukin-8 and growth-related gene product alpha is present in the colonic mucosa of inflammatory bowel. Scand J Gastroenterol, 2001, 36(8): 854-864

[18] KeshavarzianA., FusunyanR.D., JacynoM., et al.. Increased intoleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am J Gastroenterol, 1999, 94(3): 704-712

[19] ZhuX.Q., ZhenJ.Z., SiX.H.. Treatment Progress on inflammatory bowel disease. Chin J Dig (Chinese), 2002, 22(10): 624-625

[20] ShanahanF.. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology, 2001, 120(3): 622-635

[21] ZhangJ.P.. Research progress on immunology of ulcerative colitis. Chin J Misdiagnostics (Chinese), 2000, 2(1): 57-59

[22] HaoW.W., MaG.T.. Research progress on pathogenesis of ulcerative colitis. Shanxi Med J (Chinese), 2002, 31(12): 1100-1102

[23] SartorR.B.. Current concepts of the etiology and pathogenesis of ulcerative colitis and crohn’s disease. Gastroenterol Clin North Am, 1995, 24(3): 475-507

[24] XiongY., ChenY.S., WangJ.P., et al.. Effect of Jiechangkang Tai on histiocyte factors TNF-α, IL-1β and IL-6 of rats with ulcerative colitis. Chin J Pathophysiol (Chinese), 2002, 18(9): 1137-1138

[25] ZhangX.F.. Cytokine and ulcerative colitis. Hebei Med (Chinese), 2001, 7(5): 465-468

[26] FanH., QiuM.Y., MeiJ.J., et al.. Effects of four regulating intestines prescriptions on pathology and ultrastructure of colonic tissue in rats with ulcerative colitis. World J Gastroenterol, 2005, 11(31): 4800-4806

[27] BaeuerleP.A., BaltimoreD.. NF-κB: ten years after. Cell, 1996, 87(1): 13-20

[28] BaeuerleP.A., HenkelT.. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol, 1994, 12: 141-179

[29] HuangW.C., ChenJ.J., ChenC.C.. c-Src-dependent tyrosine phosphorylation of IKKbeta is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression. J Biol Chem, 2003, 278(11): 9944-9952

[30] FanH., ChenR., ShenL., et al.. Oxymatrine improves TNBS-induced colitis in rats by inhibiting the expression of NF-κB p65. J Huazhong Univ Sci Technol Med Sci, 2008, 28(4): 415-420